NovoCure Ltd (NVCR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Asaf Danziger
Employees:
598
44 (0)15 3475 6700

Novocure Ltd. operates as a commercial-stage oncology company, which offers devices for continuous home use by patients. It develops novottf-100A, a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

Data derived from most recent annual or quarterly report
Market Cap 9.676 Billion Shares Outstanding103.648 Million Avg 30-day Volume 670.612 Thousand
P/E Ratio1156.7277 Dividend Yield0.0 EPS-0.13
Price to Revenue25.7308 Debt to Equity1.5037 EBITDA47.728 Million
Price to Book Value36.4549 Operating Margin6.390700000000001 Enterprise Value13.25 Billion
Current Ratio9.189 EPS Growth0 Quick Ratio8.661
1 Yr BETA 1.5023 52-week High/Low 232.76 / 90.95 Profit Margin2.2244
Operating Cash Flow Growth249.5409 Altman Z-Score12.4899 Free Cash Flow to Firm 22.129 Million
View SEC Filings from NVCR instead.

View recent insider trading info

Funds Holding NVCR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVCR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 3 transactions

Open Market Sells (S)

209 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DANZIGER ASAF CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
13,276 2021-11-26 6

CORDOVA ASHLEY CHIEF FINANCIAL OFFICER

  • Officer
41,758 2021-11-02 8

GROENHUYSEN WILHELMUS CM CHIEF OPERATING OFFICER

  • Officer
149,899 2021-09-02 8

SHAH PRITESH CHIEF COMMERCIAL OFFICER

  • Officer
73,512 2021-09-02 12

LEONARD FRANK X CHIEF DEVELOPMENT OFFICER

  • Officer
87,153 2021-09-02 7

BURKE WILLIAM PATRICK CHIEF HUMAN RESOURCES OFFICER

  • Officer
26,217 2021-09-01 1

LEUNG GABRIEL

  • Director
75,204 2021-08-05 6

MADDEN MARTIN J.

  • Director
16,004 2021-08-05 3

BENAIM ELY CHIEF MEDICAL OFFICER

  • Officer
28,144 2021-08-03 11

DOYLE WILLIAM F EXECUTIVE CHAIRMAN

  • Officer
  • Director
554,398 2021-08-02 3

LONGSWORTH TODD CHRISTOPHER GENERAL COUNSEL

  • Officer
67,868 2021-07-06 6

WEINBERG URI CHIEF SCIENCE OFFICER

  • Officer
31,780 2021-07-06 6

HILLEMAN JERYL L

  • Director
4,443 2021-06-09 2

HUNG DAVID

  • Director
8,213 2021-06-09 1

VERNON W ANTHONY

  • Director
163,443 2021-06-09 1

MCCOY SHERILYN S

  • Director
8,213 2021-06-09 1

SCANNELL TIMOTHY J

  • Director
7,929 2021-03-02 2

AMBROGI MICHAEL J. CHIEF OPERATING OFFICER

  • Officer
220,867 2020-07-21 0

WYSS HANSJOERG

  • 10% Owner
No longer subject to file 2019-12-20 0

PHILLIPS CHARLES G III

  • Director
3,359 2019-12-02 0

BURKOTH WILLIAM T.

  • Director
6,145 2019-05-21 0

KIRSON EILON D. CHIEF SCIENCE OFFICER

  • Officer
152,408 2019-02-27 0

PALTI YORAM CHIEF TECHNOLOGY OFFICER

  • Officer
  • Director
1,041,054 2018-08-28 0

POMONA CAPITAL VII, L.P.

POMONA CAPITAL VII FUND INVESTORS, L.P.

POMONA ASSOCIATES VII, L.P.

POMONA SECONDARY ASSOCIATES VII LLC

POMONA G.P. HOLDINGS LLC

GRANOFF MICHAEL D

JANIS FRANCES

FUTRELL STEVE

  • 10% Owner
No longer subject to file 2017-06-23 0

LAVIGNE LOUIS J JR

  • Director
0 2017-05-31 0

PERLHAGEN GERT L.

  • Director
0 2017-05-10 0

DOYLE WILLIAM F EXECUTIVE CHAIRMAN

WFD VENTURES FUND II, L.P.

  • Officer
  • Director
  • 10% Owner
753,653 2017-03-08 0

MELNYK PETER M. CHIEF COMMERCIAL OFFICER

  • Officer
2,403 2017-01-06 0

VOLATI LTD

  • 10% Owner
No longer subject to file 2016-08-05 0

PERLHAGEN GERT L.

VOLATI LTD

  • Director
  • 10% Owner
7,893,365 2016-05-06 0

LANGLOSS TIMOTHY J.

  • Director
No longer subject to file 2016-05-05 0

MYLOD ROBERT J JR

  • Director
0 2016-05-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DANZIGER ASAF - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-29 16:48:17 -0500 2021-11-26 P 1,000 $103.37 a 13,172 direct

DANZIGER ASAF - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-29 16:48:17 -0500 2021-11-26 P 3,870 $102.36 a 12,172 direct

DANZIGER ASAF - Director - Officer CHIEF EXECUTIVE OFFICER

2021-11-29 16:48:17 -0500 2021-11-26 P 104 $96.50 a 13,276 direct

CORDOVA ASHLEY - Officer CHIEF FINANCIAL OFFICER

2021-11-03 16:11:05 -0400 2021-11-02 S 209 $107.28 d 41,758 direct -0.449 4.5182 4.5182 6 -3.7138 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NOVOCURE LTD NVCR 2021-11-30 17:45:03 UTC -0.1864 0.2564 450000
NOVOCURE LTD NVCR 2021-11-30 17:15:03 UTC -0.1864 0.2564 450000
NOVOCURE LTD NVCR 2021-11-30 16:45:03 UTC -0.1906 0.2606 450000
NOVOCURE LTD NVCR 2021-11-30 16:15:02 UTC -0.1906 0.2606 450000
NOVOCURE LTD NVCR 2021-11-30 15:45:03 UTC -0.1906 0.2606 450000
NOVOCURE LTD NVCR 2021-11-30 15:15:04 UTC -0.1906 0.2606 500000
NOVOCURE LTD NVCR 2021-11-30 14:45:02 UTC -0.1982 0.2682 500000
NOVOCURE LTD NVCR 2021-11-30 14:15:03 UTC -0.1982 0.2682 500000
NOVOCURE LTD NVCR 2021-11-30 13:45:03 UTC -0.1982 0.2682 500000
NOVOCURE LTD NVCR 2021-11-30 13:15:03 UTC -0.1982 0.2682 450000
NOVOCURE LTD NVCR 2021-11-30 12:45:03 UTC -0.1982 0.2682 450000
NOVOCURE LTD NVCR 2021-11-29 22:15:03 UTC -0.1985 0.2685 400000
NOVOCURE LTD NVCR 2021-11-29 21:45:03 UTC -0.1985 0.2685 400000
NOVOCURE LTD NVCR 2021-11-29 21:15:03 UTC -0.1985 0.2685 400000
NOVOCURE LTD NVCR 2021-11-29 20:45:03 UTC -0.1994 0.2694 400000
NOVOCURE LTD NVCR 2021-11-29 20:15:03 UTC -0.1994 0.2694 400000
NOVOCURE LTD NVCR 2021-11-29 19:45:03 UTC -0.1994 0.2694 400000
NOVOCURE LTD NVCR 2021-11-29 19:15:04 UTC -0.1994 0.2694 400000
NOVOCURE LTD NVCR 2021-11-29 18:45:03 UTC -0.2 0.27 400000
NOVOCURE LTD NVCR 2021-11-29 18:15:03 UTC -0.2 0.27 400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund NVCR -2049.0 shares, $-270836.82 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund NVCR -400.0 shares, $-88728.0 2021-06-30 N-PORT
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund NVCR -4337.0 shares, $-667941.37 2021-07-31 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund NVCR -112800.0 shares, $-17372328.0 2021-07-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund NVCR -20.0 shares, $-3080.2 2021-07-31 N-PORT
CLOUGH GLOBAL LONG/SHORT FUND- Clough Global Long/Short Fund NVCR -2375.0 shares, $-365773.75 2021-07-31 N-PORT
CLOUGH GLOBAL EQUITY FUND- Clough Global Equity Fund NVCR -12105.0 shares, $-1864291.05 2021-07-31 N-PORT
CLOUGH GLOBAL DIVIDEND AND INCOME FUND- Clough Global Dividend and Income Fund NVCR -5450.0 shares, $-839354.5 2021-07-31 N-PORT
CLOUGH GLOBAL OPPORTUNITIES FUND- Clough Global Opportunities Fund NVCR -22680.0 shares, $-3492946.8 2021-07-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND NVCR -650.0 shares, $-100106.5 2021-07-31 N-PORT
GMO TRUST- GMO Implementation Fund NVCR -50000.0 shares, $-6710500.0 2021-08-31 N-PORT
GMO TRUST- GMO Benchmark-Free Fund NVCR -17800.0 shares, $-2388938.0 2021-08-31 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund NVCR -3000.0 shares, $-402630.0 2021-08-31 N-PORT
GMO TRUST- GMO Alternative Allocation Fund NVCR -2700.0 shares, $-362367.0 2021-08-31 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund NVCR 719.0 shares, $-96496.99 2021-08-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund NVCR -800.0 shares, $-92936.0 2021-09-30 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund NVCR -344.0 shares, $-39962.48 2021-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund NVCR -1983.0 shares, $-230365.11 2021-09-30 N-PORT
AQR Funds- AQR Multi-Asset Fund NVCR -443.0 shares, $-51463.31 2021-09-30 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund NVCR -395.0 shares, $-45887.15 2021-09-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio NVCR -6200.0 shares, $-720254.0 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund NVCR -96.0 shares, $-11152.32 2021-09-30 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND NVCR -6466.0 shares, $-751155.22 2021-09-30 N-PORT

Elevate your investments